Drug Delivery: Infusion Devices

Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. The combined global market for infusion DDT products totaled nearly $9.9bn in 2017, and is expected to climb at a rate of 6.4% over the forecast period. Technological advancements, such as devices with needlestick prevention features and dose error reduction software, are a driver of the infusion DDT market. The largest absolute gains are expected to occur in the insulin pumps segment, which accounts for nearly half of the total infusion products market and is expected to increase at a CAGR of approximately 9.1% over the forecast period. Since the introduction of smart pumps, the formerly flat volumetric pumps market has registered significant gains in dollar volume, driven primarily by the replacement of older volumetric pumps with enhanced-safety, informatics-loaded infusion instruments.